Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Howson-Jan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Dermatology Online Journal|July 24, 2009
Hodgkin lymphoma with cutaneous involvementCyrus C Hsia, Kang Howson-Jan, Kamilia S Rizkalla
Journal of Clinical Apheresis|February 22, 2013
Predictors of unsuccessful mobilization with granulocyte colony-stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantationSigny Chow, Alejandro Lazo-Langner, George Ormond, et al.
Sarcoma|June 4, 2008
High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian CentreSébastien J Hotte, Anne M Smith, Vivien H C Bramwell, et al.
British Journal of Haematology|August 28, 2014
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O(6) -methylguanine DNA methyltransferase expressionJoseph M Brandwein, Jeannine Kassis, Brian Leber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2004
An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allograftingChristopher Bredeson, Chantal Leger, Stephen Couban, et al.
Cancer|September 24, 2004
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)Michael Crump, Tara Baetz, Stephen Couban, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplantA Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Blood|August 15, 2002
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignanciesStephen Couban, David R Simpson, Michael J Barnett, et al.
Leukemia & Lymphoma|June 9, 2016
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12<sup/>Tara Baetz, Bingshu E Chen, Stephen Couban, et al.
British Journal of Haematology|June 27, 2020
Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndromeEri Kawata, Alejandro Lazo-Langner, Anargyros Xenocostas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Dermatology Online Journal|July 24, 2009
Hodgkin lymphoma with cutaneous involvementCyrus C Hsia, Kang Howson-Jan, Kamilia S Rizkalla
Journal of Clinical Apheresis|February 22, 2013
Predictors of unsuccessful mobilization with granulocyte colony-stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantationSigny Chow, Alejandro Lazo-Langner, George Ormond, et al.
Sarcoma|June 4, 2008
High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian CentreSébastien J Hotte, Anne M Smith, Vivien H C Bramwell, et al.
British Journal of Haematology|August 28, 2014
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O(6) -methylguanine DNA methyltransferase expressionJoseph M Brandwein, Jeannine Kassis, Brian Leber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2004
An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allograftingChristopher Bredeson, Chantal Leger, Stephen Couban, et al.
Cancer|September 24, 2004
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)Michael Crump, Tara Baetz, Stephen Couban, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplantA Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Blood|August 15, 2002
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignanciesStephen Couban, David R Simpson, Michael J Barnett, et al.
Leukemia & Lymphoma|June 9, 2016
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12<sup/>Tara Baetz, Bingshu E Chen, Stephen Couban, et al.
British Journal of Haematology|June 27, 2020
Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndromeEri Kawata, Alejandro Lazo-Langner, Anargyros Xenocostas, et al.
Pageof 2